Skip to content

Raltegravir 800mg twice daily appears a good alternative to efavirenz for HIV-TB treatment

Novel TB combination regimen shows potent activity in randomised short-term clinical trial

Novel TB combination regimen shows potent activity in randomised short-term clinical trial

Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy

HIV and TB in Practice for nurses: integration and decentralisation

Low CD4 cell count and older age associated with increased risk of TB after starting HIV therapy

Investing in national TB programmes has a real impact on burden of the disease

A low CD4 cell count, weight and haemoglobin can identify which HIV-positive patients are more likely to have undiagnosed TB

TB, HIV, mothers and children: time for action

World Health Organization issues new policy to step up TB/HIV efforts